Skip to main content

Advertisement

SpringerLink
Log in

Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

This study was conducted to evaluate the role of tumor suppressor gene ras homologue member I (ARHI) in human glioma tumors. We examined expression of ARHI in human glioma tumors and normal brain tissue and also in 4 different glioma cell lines. Furthermore, the effects of ARHI over-expression produced by cellular transfection on the growth of human glioma U251 cells cultured in vitro were also studied. Expression of ARHI was evaluated in samples of glioma tumors obtained from 59 patients who underwent surgery at the Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China. Ten samples of normal brain tissue were used as controls. Additionally, in vitro studies were conducted in which a recombinant vector carrying ARHI cDNA was constructed and transfected into U251 glioma cells with reduced expression of ARHI. Following transfection, the MTT assay, flow cytometry, TUNEL procedure, Transwell assay, and wound-healing test were employed to evaluate the biological functions of ARHI in U251 glioma cells in vitro. Analyses of mRNA and protein expression revealed that ARHI was significantly down-regulated in glioma tissues as well as in 4 malignant glioma cell lines. Over-expression of ARHI resulted in suppression of glioma cell proliferation, arrest of cell cycle progression, reduction in cell migration and invasion, and promotion of cell apoptosis. Collectively, our data highlight the importance of ARHI in glioma progression and provide the first biological basis for ARHI as a novel candidate target for gene therapy of glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hess KR, Broglio KR, Bondy ML. Adult glioma incidence trends in the United States, 1977–2000. Cancer. 2004;101:2293–9.

    Article  PubMed  Google Scholar 

  2. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–21.

    Article  CAS  PubMed  Google Scholar 

  3. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21(21):2683–710.

    Article  CAS  PubMed  Google Scholar 

  4. An S, Nam K, Choi S, Bai CZ, Lee Y, Park JS. Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic. Int J Nanomed. 2013;8:821–34.

    Google Scholar 

  5. Marsh JC, Goldfarb J, Shafman TD, Diaz AZ. Current status of immunotherapy and gene therapy for high-grade gliomas. Cancer Control. 2013;20(1):43–8.

    PubMed  Google Scholar 

  6. Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC Jr, Yu Y. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer. 2000;86:690–4.

    Article  CAS  PubMed  Google Scholar 

  7. Hu YQ, Si LJ, Ye ZS, Lin ZH, Zhou JP. Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity. Mol Med Rep. 2013;7(4):1180–4.

    CAS  PubMed  Google Scholar 

  8. Huang J, Lin Y, Li L, Qing D, Teng XM, Zhang YL, Hu X, Hu Y, Yang P, Han ZG. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Mol Carcinog. 2009;48:130–40.

    Article  CAS  PubMed  Google Scholar 

  9. Wu X, Liang L, Dong L, Yu Z, Fu X. Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro. Mol Biol Rep. 2013;40(3):2671–8.

    Article  CAS  PubMed  Google Scholar 

  10. Lu X, Qian J, Yu Y, Yang H, Li J. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest. Oncol Rep. 2009;22(3):635–40.

    Article  CAS  PubMed  Google Scholar 

  11. Yu Y, Luo R, Lu Z, Wei Feng W, Badgwell D, Issa JP, Rosen DG, Liu J, Bast RC. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol. 2006;407:455–68.

    Article  CAS  PubMed  Google Scholar 

  12. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB, Bast RC Jr. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA. 1999;96:214–9.

    Article  CAS  PubMed  Google Scholar 

  13. Janssen EA, Øvestad IT, Skaland I, Søiland H, Gudlaugsson E, Kjellevold KH, Nysted A, Søreide JA, Baak JP. LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer. Cell Oncol. 2009;31(5):335–43.

    CAS  PubMed  Google Scholar 

  14. Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res. 2008;10:R22.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir EG. Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin Cancer Res. 2006;12:6331–6.

    Article  CAS  PubMed  Google Scholar 

  16. Hisatomi H, Nagao K, Wakita K, Kohno N. ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology. 2002;62:136–40.

    Article  CAS  PubMed  Google Scholar 

  17. Li Y, Shi L, Han C, Wang Y, Yang J, Cao C, Jiao S. Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells. Tumour Biol. 2012;33(5):1403–10.

    Article  CAS  PubMed  Google Scholar 

  18. Lu Z, Bast RC Jr. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Cell Adh Migr. 2013;7(2):232–6.

    Article  PubMed  Google Scholar 

  19. Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE, Waite KA, Eng C. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab. 2005;90:1149–55.

    Article  CAS  PubMed  Google Scholar 

  20. Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene. 2003;22:2897–909.

    Article  CAS  PubMed  Google Scholar 

  21. Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN, LaPushin R, Andreeff M, Fang B, Yu Y, Bast RC Jr. Re-expression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 2002;62:7264–72.

    CAS  PubMed  Google Scholar 

  22. Zhang H, Zhu W, Su X, Wu S, Lin Y, Li J, Wang Y, Chen J, Zhou Y, Qiu P, Yan G, Zhao S, Hu J, Zhang J. Triptolide inhibits proliferation and invasion of malignant glioma cells. J Neurooncol. 2012;109(1):53–62.

    Article  CAS  PubMed  Google Scholar 

  23. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture. Med Oncol. 2007;24:231–8.

    Article  CAS  PubMed  Google Scholar 

  24. Xu L, Ding X, Tan H, Qian J. Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer. Cancer Cell Int. 2013;13(1):81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Singh N, Das P, Datta Gupta S, Sahni P, Pandey RM, Gupta S, Chauhan SS, Saraya A. Prognostic significance of extracellular matrix degrading enzymes-cathepsin L and matrix metalloproteases-2 [MMP-2] in human pancreatic cancer. Cancer Invest. 2013;31(7):461–71.

    Article  CAS  PubMed  Google Scholar 

  26. Wang G, Wang W, Zhou J, Yang X. Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer. Cancer Biomark. 2013;13(1):21–8.

    CAS  PubMed  Google Scholar 

  27. Honda T, Yamamoto I, Inagawa H. Angiogenesis-, metastasis- and signaling pathway-related factor dynamics in human colon cancer cells following interaction with monocytes. Anticancer Res. 2013;33(7):2895–900.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by the Young Scientist Project of Fujian Province Science Foundation (2013J05113).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, The Affiliated Union Hospital of Fujian Medical University, Fujian Neurosurgical Institute, 29# Xinquan Road, Fuzhou, 350001, Fujian, China

    Jing Chen, Songsheng Shi, Weizhong Yang & Chunmei Chen

Authors
  1. Jing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Songsheng Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weizhong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chunmei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J., Shi, S., Yang, W. et al. Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma. Med Oncol 31, 846 (2014). https://doi.org/10.1007/s12032-014-0846-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0846-2

Keywords

Search

Navigation